Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy
type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology …

Background Cardiac involvement is a major determinant of prognosis in type 1 myotonic
dystrophy (DM1), but limited information is available about myocardial remodeling and …

Background Myotonic dystrophy type 1 (MD1) is a neuromuscular disorder with potential
involvement of the heart and increased risk of sudden death. Considering the importance of …

Introduction Left ventricular (LV) dysfunction is a major prognostic determinant in myotonic
dystrophy type 1 (DM 1). Therefore, markers of early‐stage LV impairment may be useful …

Background Cardiac involvement represents a major cause of morbidity and mortality in
patients with myotonic dystrophy type 1 (DM1) and prevention of sudden cardiac death …

Background—Myotonic dystrophy type 2 (DM2) is a genetic disorder characterized by
skeletal muscle symptoms, metabolic changes, and cardiac involvement. Histopathologic …

BACKGROUND: Myotonic dystrophy type 1 (DM1) is a neurological disorder with known
cardiac involvement, including conduction disturbances, arrhythmias, and ventricular …

Background Patients with myotonic dystrophy type 1 (DM1) have a three-fold higher risk of
sudden cardiac death (SCD) than age-matched healthy controls. Despite numerous …

Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults. Cardiac
involvement is reported in 80% of cases and includes conduction disturbances, arrhythmias …

Background Frequency and severity of cardiac involvement in DM2 are still controversial.
The aims of our study were to determine the frequency and progression of cardiac and …